Larvol Delta - Bimekizumab-Demonstrated-Consistent-Efficacy-and-Safety-in-Patients-with-Active-Psoriatic-Arthritis-Classed-as-Obese-or-Overweight-3Year-Pooled-Post-Hoc-Results-from-Two-Phase-3-Studies

Bimzelx (bimekizumab-bkzx) - UCB

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1899168&mode=presInfo

Jessica Walsh, MD, MBA

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next